Abstract #1069: Tigatuzumab (CS-1008), a novel humanized DR5 agonist antibody, eradicates pancreas cancer stem cells and results in long term cures, in combination with gemcitabine, in direct pancreas cancer xenografts
Year: 2009
Type: conference-abstract
Source: Cancer Research
Authors: N.V. Rajeshkumar, Zeshaan A. Rasheed, Elena García-García, Antonio Jimeno, Kôsaku Fujiwara, William Matsui, Manuel Hidalgo
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3111132091